Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
2018; Ferrata Storti Foundation; Volume: 103; Issue: 10 Linguagem: Espanhol
10.3324/haematol.2018.188680
ISSN1592-8721
AutoresEsteban E. Elías, María Belén Almejún, Ana Colado, Gregorio Cordini, Maricef Vergara-Rubio, Enrique Podaza, Denise Risnik, María Cabrejo, Horacio Fernández-Grecco, Raimundo Bezares, Maria Del Rosario Custidiano, Julio César Sánchez-Ávalos, Ángeles Vicente, Gonzalo Garate, Mercedes Borge, Mirta Giordano, Romina Gamberale,
Tópico(s)Monoclonal and Polyclonal Antibodies Research
ResumoFil: Elias, Esteban Enrique. Consejo Nacional de Investigaciones Cientificas y Tecnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina. Academia Nacional de Medicina de Buenos Aires; Argentina
Referência(s)